EISSN 2980-1478

INDEXED IN WEB OF SCIENCE AND SCOPUS INDEXED IN PUBMED CENTRAL

Urology Research & Practice

50 218 2024

HIGHLY CITED ARTICLES

Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study

By: Shah et al.

What do urologists need to know: Diagnosis, treatment, and follow-up during COVID-19 pandemic

By: Ho et al.

Thulium fiber laser: The new kid on the block

By: Schembri et al.

Urine miR-21-5p and miR-200c-3p as potential non-invasive biomarkers in patients with prostate cancer

By: Danarto et al.

The role of fluid intake in the prevention of kidney stone disease: A systematic review over the last two decades

By: Gamage et al.

Platelet-to-lymphocyte ratio and systemic immune-inflammation index versus circulating prostate cells to predict significant prostate cancer at first biopsy

By: Murray et al.

Problems and solutions of stent biofilm and encrustations: A review of literatüre

By: Khoddami et al.

First case of retroperitoneal hematoma in COVID-19

By: Scialpi et al.

Holmium laser enucleation of the prostate for the treatment of size-independent BPH: A single-center experience of 600 cases

By: Yalçın et al.

Transperineal prostate biopsy: The modern gold standard to prostate cancer diagnosis

By: By: Ortner et al.

UROONCOLOGY - Review

Prognostic Markers and Trials in Penile Cancer

Naufal Naushad ¹ , Abdalla A. Deb ² , Ayman A. Agag ³ , Hosam A. Serag ⁴ , Vijay K. Sangar ¹

Author Affiliation(s)

1.

Department of Urology, Christie NHS Foundation Trust, Manchester, UK

2.

Department of Urology, James Cook University Hospital, Middlesbrough, UK

3.

Department of Urology, Frimley Park Hospital, Frimley, UK

4.

Department of Urology, University Hospitals Birmingham, Birmingham, UK

Urol Res Pract 2023; 49: 138-146

DOI: 10.5152/tud.2023.22225

Keywords : Lymphatic metastasis, penile neoplasms, prognosis, squamous cell carcinoma- related antigen, survival

Read: 1502 Downloads: 641 Published: 17 May 2023

Volume 49, Issue 3, May 2023

Previous Article

New tumor biomarkers open the potential for designing personalized therapy for penile squamous cell carcinoma. Despite the initial promising results of some biomarkers, controversy remains due to contradictory studies. Further robust research work is required before incorporating biomarkers in the personalized management of penile cancer. This narrative review aims to highlight some of the most commonly and recently investigated biomarkers of penile cancer and to summarize the ongoing registered clinical trials for the management of penile cancer patients.

Cite this article as: Naushad N, Deb AA, Agag AA, Serag HA, Sangar VK. Prognostic markers and trials in penile cancer. Urol Res Pract. 2023;49(3):138-146.

Files